written on 21.03.2014

Novartis's Bexsero to be used in UK national program, subject to price


The Joint Committee on Vaccination and Immunisation (JCVI) in the UK has recommended the inclusion of Bexsero saying the vaccine should be routinely used in infants from two months of age to help protect against meningitis B.